维莫德吉Erivedge（vismodegib）

[Jimin Pharmaceutical Guide] Vismodegib is used to treat a type of skin cancer – basal cell carcinoma.

This product is a tablet, 28 tablets per bottle, each tablet contains 150 mg of active ingredient.

Vismodegib was approved by the US Food and Drug Administration on January 30, 2012 for the treatment of advanced metastatic basal cell carcinoma. This product was developed and produced by Genentech.